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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) are
known to modulate fetal growth but their role in intrauterine growth of monochorionic twins
(MCT) has not been studied.
Methods: Cord venous blood was collected directly after birth. IGF-1 and IGFBP-3 in the cord
venous blood were quantified by radioimmunoassay. Birth weights (BWs) were obtained elec-
tronically. Placentas were examined for chorionicity.
Results: Cord blood was collected in 37 pairs of MCT (15 pairs were males). BWs ranged from 564
to 3240 g, and gestational ages (GAs) were between 24 weeks and 39 weeks. There was a corre-
lation between BW and cord venous blood IGFBP-3 concentration (rZ 0.28, pZ 0.015), but not
between BW and cord venous blood IGF-1 level. There was no difference in IGF-1 between the
heavier twins (30.8 61.8 ng/mL) and lighter twins (33.2 63.7 ng/mL), but a trend (pZ 0.096)
of higher IGFBP-3 level was demonstrated in heavier twins (3.14  1.23 mg/mL) than in lighter
twins (2.71  1.19 mg/mL). The IGFBP-3 levels were higher (p Z 0.042) in female twins
(3.20 1.33 mg/mL) than in male twins (2.64 1.04 mg/mL). The IGF-1 level of the heavier twins
correlated significantly to their lighter co-twin (rZ 0.73, p < 0.001).
Conclusion: Our data showed that cord venous blood IGF-1 level might be controlled mainly by
genetic factors. IGFBP-3 might play an important role in fetal growth.
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Insulin-like growth factors (IGFs) are a family of poly-
peptides with growth promoting and insulin-like activities,
separated into two main classes, IGF-1 and IGF-2, by their
molecular weight and biological properties.1 Intrauterine
fetal growth is believed to be controlled by both the IGF
axis and maternal factors.2,3 The actions of the IGFs are
modulated by insulin-like growth factor binding proteins
(IGFBPs).4 Six binding proteins, IGFPB-1 to IGFBP-6, have
been characterized to date,5,6 of which IGFBP-3 is the most
important in human blood.6 There were several studies
demonstrating that serum IGF-1 levels correlated positively
with fetal weight, length, and placental weight.7e9
Because of the wide variation of IGF-1 in cord blood, and
complex interplay among IGFs and IGFBPs, contradictory
results were seen from previous studies.10 Study in full-
term newborn infants demonstrated a good correlation
between IGFBP-3 level and birth weight (BW).11In an
attempt to confirm the relationship between cord IGF-1
and IGFBP-3 levels and fetal growth, we selected mono-
chorionic twins as our study subjects due to their identical
genetic makeup.Subjects and methods
A total of 37 pairs of monochorionic twins, delivered in the
National Taiwan University Hospital, were enrolled pro-
spectively in our study. Informed consent was waived by
the Institutional Review Board because cord blood was
viewed as medical waste as long as patients’ identifiers
were not reported. Cord venous blood was collected and
centrifuged at 3000 rpm for 15 minutes and plasma was
stored at 80C until analysis. Monochorionicity was con-
firmed by placental inspection and milk injection. BW was
measured to the nearest gram using electronic scales.
The IGF-1and IGFBP-3 levels were quantified by radio-
immunoassay kits (Nichols Institute Diagnostics, San Juan
Capistrano, CA, USA) in triplicate. An acideethanol
extraction method was used for sample preparation before
the IGF-1 radioimmunoassay.12 All reagents required for the
assay were prepared according to the manufacturers’
instructions. The sensitivity was 0.3 ng/mL with intra-assay
variation below 3.0% and inter-assay variation below 8.4%.
In the IGFBP-3 assay, the sensitivity was 0.12 mg/mL with
the intra-assay variation below 8.0% and the inter-assay
variation below 6.3%.
The paired Wilcoxon test was used to compare the IGF-1
and IGFBP-3 levels between heavy and light twins for their
skewed distributions. The Mann-Whitney U test was used
for other comparisons. To compare the proportions of small
for gestational age (GA), the Chi-squared test was used. A p
value < 0.05 was considered statistically significant.Figure 1 The relationship between cord venous blood
insulin-like growth factor binding protein-3 (IGFBP-3) and birth
weight (BW) (r Z 0.28, p Z 0.015).Results
There were 15 pairs of male twins and 22 pairs of female
twins enrolled. The GAs ranged from 24 weeks to 39 weeks.
The BWs ranged from 600 g to 3098 g. Six of the 37 heavy
twins were small for GA (<10th percentile of correspondingGA)13 as compared to 17 of 37 of their light co-twins [Chi-
squared test 7.63, odds ratio (OR) 0.228, 95% confidence
interval (CI) 0.077e0.675, p < 0.01]. The GA was similar
between male twins (35  3 weeks) and female twins
(35  2 weeks). There was no difference in BWs between
male twins (2161  514 g) and female twins (2198  480 g).
IGF-1 levels were between 11.25 ng/mL and 402.75 ng/mL,
and IGFBP-3 levels were between 0.24 mg/mL and 6.30 mg/
mL. No difference (p > 0.5) was detected between male
and female twins in respect of body length and head cir-
cumference in our subjects.
Significant positive correlation was observed between
BW and IGFBP-3 concentration (r Z 0.28, p Z 0.015)
(Fig. 1) but such correlation was not observed between BW
and IGF-1. We also failed to detect any correlation between
birth length and IGF-1 level (p > 0.5). There was no dif-
ference in cord venous blood IGF-1 between heavy twins
(30.8  61.8 ng/mL) and light twins (33.2  63.7 ng/mL)
(Fig. 2), but a trend (p Z 0.096) towards higher IGFBP3
levels could be demonstrated in heavy twins
(3.14  1.23 mg/mL) compared to light twins
(2.71  1.19 mg/mL) (Fig. 3). The IGFBP3 levels were sig-
nificantly higher (p Z 0.042) in female twins
(3.20  1.33 mg/mL) than in male twins (2.64  1.04 mg/
mL). The IGF-1 level of the heavy twins correlated sig-
nificantly with their co-twins (rZ 0.75, p < 0.001), but the
IGFBP3 level did not (p Z 0.24). After controlling for BW,
sex, birth length, head circumference, and GA, there were
no differences for IGF-1 (F Z 1.6, p Z 0.21) and IGFBP-3
(F Z 0.002, p Z 0.96) between small-for-GA and
appropriate-for-GA twins.
Discussion
Two IGFs have been studied to date in human subjects, IGF-
1 and IGF-2, and the cord blood levels have been shown to
correlate with gestational age14 or birth weight7,15 of the
newborn infants. Low IGFs have been shown in small-for-GA
infants.16 In term infants, the cord levels of IGF-1 and
IGFBP3 significantly correlate with BW, Ponderal index, and
placental weight.17 Owing to a variety of bioassay
Figure 2 The distribution of cord venous blood insulin-like
growth factor-1 (IGF-1) levels.
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results have not been conclusive to date.9 Intrauterine
growth retarded infants have significantly lower levels of
IGF-116,18 and IGFBP-3,19 but conflicting results have been
reported.9
The actions of the IGFs are modulated by the IGFBPs.4
IGFBP-3 is the most important one: it accounts for the
majority of IGF binding, and it serves as the reservoir of
IGFs.6 Decreased levels of IGFBP-3 have been shown in the
cord blood of intrauterine growth retarded infants.20
Monochorionic twins, with identical genetic makeup, are
useful to study the relationship between IGFs, IGFBPs, and
fetal growth. It has been shown that monozygotic twin
children have high within-pair correlation of IGF-1.21 A
similar result has also been shown in adult twins.21 The
results of these studies suggest a genetic contribution to
the inter-individual variation of the levels of IGF-1 post-
natally. Although mutations in genes controlling IGF, IGFPB,
and IGF receptors have been reported to be associated with
intrauterine growth retardation, the results obtained fromFigure 3 The distribution of cord venous blood insulin-like
growth factor binding protein-3 (IGFBP3) levels.our study subjects, monochorionic twins, may eliminate
most of these concerns. We demonstrated the within-pair
correlation of the cord venous levels of IGF-1 in mono-
chorionic twins. Our model removed the environmental
effects on IGF-1 and IGFBP-3 and further strengthens the
genetic contribution of the IGF axis in fetal growth. From
our results, we believe that the correlation between BW
and cord level of IGF-1 in previous reports may be a sec-
ondary effect. It is the environmental factors that deter-
mined the BW rather than IGF-1 level. Judging from the
high heritability of IGF-1in a recent twin study, we believe
that IGF-1 levels are determined mainly by genetic
attributes.22,23
Our data show that the cord venous IGFBP-3 level is
higher in females than in males, which is similar to twin
studies performed in adults.23 However, we failed to show
significant intra-twin correlation in IGFBP-3 levels. The
significance of higher IGFBP-3 in female infants is unclear,
because our results showed that IGFBP-3 levels were cor-
related with BW but there was no weight difference
between male twins and female twins. Further studies may
be required to clarify this issue.
In conclusion, our data suggests that the IGF-1 level in
cord blood is more genetically determined, whereas IGFBP3
may play an important role in determining fetal growth.
Due to the low prevalence of monochorionicity, our data
fail to answer several important issues. Future collabo-
ration among major centers may provide more information
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